Travere Therapeutics stock hits 52-week high at 67.97 USD

Markets Investing.com By Investing.com 03 Sep 2026 14:08 1 min read

Covered in this story

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.